NCT04870268

Brief Summary

Several interventional and surgical procedures are available to treat moderate-to-critical acute pancreatitis (AP) in its late phase. The ongoing debate on these options, together with the scarcity of reported mid-term follow-up information in the Literature, prompted the investigators to conduct a review of our surgical experience, focused on those issues. The investigators reviewed retrospectively all the patients treated for moderate-to-critical AP according to Determinant-Based Classification (DBC), in the last nine years. Patients treated conservatively or operated within 4 weeks of the onset of the pancreatitis were excluded. All the included patients were managed following a "tailored" step-up approach, and divided into four groups, according to the first interventional procedure performed: percutaneous drainage (PD), endoscopic approach (END), internal derivation (INT), and necrosectomy (NE). In-hospital and mid-term follow-up variables, including a quality-of-life assessment, were analyzed and compared.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
47

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2012

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
8.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2020

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2021

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 13, 2021

Completed
20 days until next milestone

First Posted

Study publicly available on registry

May 3, 2021

Completed
Last Updated

May 3, 2021

Status Verified

April 1, 2021

Enrollment Period

8.3 years

First QC Date

April 13, 2021

Last Update Submit

April 28, 2021

Conditions

Keywords

acute pancreatitiswalled-off necrosissurgical treatmentquality of life

Outcome Measures

Primary Outcomes (1)

  • Satisfaction assessed by the SF-36 (36-Item Short Form Survey)

    English Standard Short Form 36 (SF-36) questionnaire is used to evaluate the general quality of life. The SF-36 examines 8 areas consisting of social and physical function, physical and emotional well-being, bodily pain, vitality, mental health and overall general health perception. The eight scaled scores are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.

    1 year

Study Arms (4)

PD group

percutaneous drainage group

Procedure: percutaneous drainage

END group

endoscopic approach group

Procedure: endoscopic approach

INT group

surgical internal derivation of WON group

Procedure: surgical internal derivation of WON

NE group

surgical necrosectomy group

Procedure: surgical necrosectomy

Interventions

PD group
END group
NE group

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The cohort sample was divided into four groups, according to the first type of the interventional or surgical management performed

You may qualify if:

  • patients treated at our referral Center for moderate to critical AP, as classified by Determinant-Based Classification of Acute Pancreatitis Severity

You may not qualify if:

  • patients who had undergone conservative treatment,
  • patients who has been operated within 4 weeks (early phase)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Di Candio G, Guadagni S, Furbetta N, Gianardi D, Palmeri M, Di Franco G, Bianchini M, Gambaccini D, Marciano E, Cervelli R, Marchi S, Morelli L. A "tailored" interventional and surgical management for moderate to critical acute pancreatitis in late phase: a cohort study. Langenbecks Arch Surg. 2022 Nov;407(7):2833-2841. doi: 10.1007/s00423-022-02557-x. Epub 2022 May 31.

MeSH Terms

Conditions

Pancreatitis

Interventions

Endoscopy

Condition Hierarchy (Ancestors)

Pancreatic DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, SurgicalDiagnostic Techniques and ProceduresDiagnosisMinimally Invasive Surgical ProceduresSurgical Procedures, Operative

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Target Duration
22 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 13, 2021

First Posted

May 3, 2021

Study Start

January 1, 2012

Primary Completion

April 1, 2020

Study Completion

January 1, 2021

Last Updated

May 3, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will not share